Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dansey

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Prostate Cancer and Prostatic Diseases|May 30, 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerR B Egerdie, F Saad, M R Smith, et al.
Bone Marrow Transplantation|April 12, 2005
Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literatureR B Ibrahim, E Peres, R Dansey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesF Saad, J E Brown, C Van Poznak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancerR S Negrin, K Atkinson, T Leemhuis, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Prostate Cancer and Prostatic Diseases|May 30, 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerR B Egerdie, F Saad, M R Smith, et al.
Bone Marrow Transplantation|April 12, 2005
Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literatureR B Ibrahim, E Peres, R Dansey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesF Saad, J E Brown, C Van Poznak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancerR S Negrin, K Atkinson, T Leemhuis, et al.
Pageof 4